Comirnaty (BNT162b2)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Comirnaty (BNT162b2), covering 2025-11-10 to 2025-12-23. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults [Phase 4]